EUVIMEDEUVIMED entdecken
Fallbericht

Hypersensitivity Reaction and a Single‐Bag Rapid Desensitization to Idursulfase

Jenna H Jung iD, Berrin Monteleone, Meghan McGath, Blanka Kaplan

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64089 ↗

Kurz gefasst

Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Jenna H Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Work Conducted While Affiliated With Northwell Health, Division of Allergy and Immunology, Department of Pediatrics, Donald and Barbara Zucker School…. Hauptthemen laut MEDLINE: Iduronate Sulfatase, Mucopolysaccharidosis II, Enzyme Replacement Therapy, Desensitization, Immunologic. Die Arbeit nennt 9 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idursulfase is the first‐line and only available enzyme replacement therapy (ERT) for Mucopolysaccharidosis type II (MPS II), or Hunter Syndrome. Deficiency in the lysosomal enzyme iduronate‐2‐sulfatase leads to progressive skeletal deformities, neurologic deterioration, airway obstruction, and cardiomyopathy. In severe cases, these deformities can lead to death during teenage years (Stapleton et al. 2017). Continuous treatment with ERT is essential to prevent irreversible changes. However, 16 out of 108 (15%) patients had hypersensitivity reactions to idursulfase during clinical trials. Hypersensitivity reactions have also been reported several years into treatment (Elaprase 2018). Therefore, it is critical to evaluate for hypersensitivity reactions and desensitize patients to idursulfase. We report a fourteen‐year‐old male who was evaluated using a nonirritating skin test concentration and underwent a novel desensitization protocol for Lysosomal Storage Disease ERT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Iduronate SulfataseMucopolysaccharidosis IIEnzyme Replacement TherapyDesensitization, ImmunologicDrug HypersensitivityHumansMaleAdolescentSkin Tests

Stichwörter der Autor:innen

desensitizationhypersensitivityidursulfasenonirritating concentration

Substanzen

Iduronate Sulfataseidursulfase

Autor:innen und Institutionen

  • Work Conducted While Affiliated With Northwell Health, Division of Allergy and Immunology, Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
  • Clinical Genetics. NYU Langone Hospital-Long Island, Long Island, New York, USA.
  • Northwell Health, Division of Allergy and Immunology, Department of Pediatrics, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.

ORCID-Profile: Jenna H Jung

Zitieren

APA

Jung, J. H., Monteleone, B., McGath, M., & Kaplan, B. (2025). Hypersensitivity Reaction and a Single‐Bag Rapid Desensitization to Idursulfase. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64089

Vancouver

Jung JH, Monteleone B, McGath M, Kaplan B. Hypersensitivity Reaction and a Single‐Bag Rapid Desensitization to Idursulfase. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64089

BibTeX
@article{Jung2025,
  author = {Jung, Jenna H and Monteleone, Berrin and McGath, Meghan and Kaplan, Blanka},
  title = {Hypersensitivity Reaction and a Single‐Bag Rapid Desensitization to Idursulfase},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64089}
}
Kostenlos starten →